ProCE Banner Activity

Evolution of TROP2-Targeted ADCs in Solid Tumors

Slideset

Download this slideset from a live symposium at AACR 2023 to review expert perspectives on structural features and current clinical data with TROP2-targeted antibody-drug conjugates, with a focus on use of these agents in breast and lung cancers.

Released: April 20, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants: AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.